Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Nurix Therapeutics (NRIX) Research & Development: 2019-2024

Historic Research & Development for Nurix Therapeutics (NRIX) over the last 6 years, with Nov 2024 value amounting to $221.6 million.

  • Nurix Therapeutics' Research & Development rose 55.22% to $86.1 million in Q3 2025 from the same period last year, while for Aug 2025 it was $301.1 million, marking a year-over-year increase of 47.51%. This contributed to the annual value of $221.6 million for FY2024, which is 17.17% up from last year.
  • Per Nurix Therapeutics' latest filing, its Research & Development stood at $221.6 million for FY2024, which was up 17.17% from $189.1 million recorded in FY2023.
  • Nurix Therapeutics' 5-year Research & Development high stood at $221.6 million for FY2024, and its period low was $66.5 million during FY2020.
  • Over the past 3 years, Nurix Therapeutics' median Research & Development value was $189.1 million (recorded in 2023), while the average stood at $198.4 million.
  • Data for Nurix Therapeutics' Research & Development shows a peak YoY surged of 75.10% (in 2021) over the last 5 years.
  • Over the past 5 years, Nurix Therapeutics' Research & Development (Yearly) stood at $66.5 million in 2020, then soared by 75.10% to $116.4 million in 2021, then surged by 58.46% to $184.5 million in 2022, then rose by 2.52% to $189.1 million in 2023, then grew by 17.17% to $221.6 million in 2024.